Minocycline Susceptibility of Carbapenem-Resistant Acinetobacter baumannii Blood Isolates from a Single Center in Korea: Role of tetB in Resistance

被引:0
作者
Kim, Taeeun [1 ]
Jeon, Eun Hee [2 ]
Hong, Yoon-Kyoung [2 ]
Jung, Jiwon [2 ]
Kim, Min Jae [2 ]
Sung, Heungsup [3 ]
Kim, Mi-Na [3 ]
Kim, Sung-Han [2 ]
Choi, Sang-Ho [2 ]
Lee, Sang-Oh [2 ]
Kim, Yang Soo [2 ]
Chong, Yong Pil [2 ]
机构
[1] Nowon Eulji Univ Hosp, Dept Med, Div Infect Dis, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, 88,Olympic Ro 43-gil, Seoul 05505, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea
关键词
Minocycline; Resistance; Acinetobacter baumannii; Efflux pump; tet8; TIGECYCLINE;
D O I
10.3947/ic.2024.0110
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) represents a devastating and growing global threat, calling for new antibiotic treatments. In Korea, the challenge of treating CRAB is compounded by high nosocomial acquisition rates and limited availability of novel antibiotics. Minocycline, a semisynthetic tetracycline derivative, has been proposed as a therapeutic option for CRAB infections. Nonsusceptibility to minocycline may occur through the efflux pump, TetB. The prevalence of tet8 in A. baumannii has increased, along with higher minocycline minimum inhibitory concentrations (MICs). We aimed to evaluate minocycline susceptibility rates in clinical strains of CRAB, and the association between tet8 carriage and minocycline susceptibility across different genotypes. Materials and Methods: Representative CRAB blood isolates were collected from Asan Medical Center, Seoul. Minocycline susceptibility was assessed using the Clinical and Laboratory Standards Institute (CLSI) breakpoint (<= 4 mg/L) and the proposed pharmacokinetics (PK)/pharmacodynamics (PD) breakpoint (<= 1 mg/L). Tigecycline was used as a comparator, and its susceptibility breakpoint for Enterobacterales defined by EUCAST was applied (<= 0.5 mg/L). The presence of tet8 was detected by PCR, and multilocus sequence typing (MLST) was performed using seven housekeeping genes. Results: Of the 160 CRAB blood isolates, 83.8% were susceptible to minocycline by the CLSI criteria, and 50.6% were PK-PD susceptible by the PK-PD criteria. The minocycline minimum inhibitory concentration (MIC)50/MIC90 was 1/8 mg/L. tet8 was present in 49% of isolates and was associated with a higher minocycline MIC (MIC50/90 2/8 mg/L vs. 1/2 mg/L). No clear correlation was observed between tet8 positivity and tigecycline MIC. Nine MLSTs were identified, with significant differences in tet8 carriage rates between the major sequence types. Notably, ST191, associated with non-tet8 carriage and greater susceptibility to minocycline, declined over the study period (P=0.004), while ST451, associated with tet8 carriage, increased. Conclusion: tet8 was present in 49% of CRAB isolates and was associated with higher MICs and non-susceptibility by both CLSI and PK-PD criteria. However, absence of tet8 was not a reliable predictor of minocycline PK-PD susceptibility. Additionally, shifts over time towards genotypes with reduced minocycline susceptibility were observed. Further research is needed to correlate these findings with clinical outcomes and identify additional resistance mechanisms.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 26 条
  • [1] Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection
    Alfouzan, Wadha A.
    Noel, A. R.
    Bowker, Karen E.
    Attwood, M. L. G.
    Tomaselli, S. G.
    MacGowan, Alasdair P.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (06) : 715 - 717
  • [2] Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future
    Asadi, Arezoo
    Abdi, Milad
    Kouhsari, Ebrahim
    Panahi, Pegah
    Sholeh, Mohammad
    Sadeghifard, Nourkhoda
    Amiriani, Taghi
    Ahmadi, Alireza
    Maleki, Abbas
    Gholami, Mehrdad
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 161 - 174
  • [3] Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii
    Bartual, SG
    Seifert, H
    Hippler, C
    Luzon, MAD
    Wisplinghoff, H
    Rodríguez-Valera, F
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4382 - 4390
  • [4] Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
    Bassetti, Matteo
    Echols, Roger
    Matsunaga, Yuko
    Ariyasu, Mari
    Doi, Yohei
    Ferrer, Ricard
    Lodise, Thomas P.
    Naas, Thierry
    Niki, Yoshihito
    Paterson, David L.
    Portsmouth, Simon
    Torre-Cisneros, Julian
    Toyoizumi, Kiichiro
    Wunderink, Richard G.
    Nagata, Tsutae D.
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (02) : 226 - 240
  • [5] Centers for Disease Control and Prevention (U.S.), 2019, Antibiotic resistance threats in the United States, 2019, DOI 10.15620/cdc:82532
  • [6] Clinical and Laboratory Standards Institue (CLSI), M100-ED34:2024 performance standards for antimicrobial susceptibility testing, V34th
  • [7] Clonal change of carbapenem-resistant Acinetobacter baumannii isolates in a Korean hospital
    Jun, So Hyun
    Lee, Da Eun
    Hwang, Hye Ryeong
    Kim, Nayeong
    Kim, Hyo Jeong
    Lee, Yoo Chul
    Kim, Yu Kyung
    Lee, Je Chul
    [J]. INFECTION GENETICS AND EVOLUTION, 2021, 93
  • [8] Kaye Keith S, 2023, NEJM Evid, V2, DOI 10.1056/evidoa2200131
  • [9] Sequencing analysis of tigecycline resistance among tigecycline non-susceptible in three species of G-ve bacteria isolated from clinical specimens in Baghdad
    Khlaif, Mariam Mahdi
    Hussein, Nadheema Hammood
    [J]. MOLECULAR BIOLOGY REPORTS, 2022, 49 (12) : 11811 - 11820
  • [10] Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance
    Linkevicius, Marius
    Sandegren, Linus
    Andersson, Dan I.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) : 789 - 796